🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and tolerability of: *...
Status
Recruiting
Location
Research Site
Start Date
2022-10-26
Trial ID
NCT05536141
Treatments Being Tested
The purpose of the study is to evaluate the progression-free survival (PFS)...
Status
Recruiting
Location
Research Site
Start Date
2025-09-08
Trial ID
NCT07011719
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Recruiting
Location
Local Institution - 0178
Start Date
2026-03-26
Trial ID
NCT07293351
Treatments Being Tested
The purpose of this study is to see whether the drug casdatifan is safe and...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2026-03-09
Trial ID
NCT07397611
Treatments Being Tested
The purpose of this study is to compare the single-dose pharmacokinetics (P...
Status
Completed
Location
Research Site
Start Date
2026-05-29
Trial ID
NCT07641881
Treatments Being Tested
This study will evaluate the safety and tolerability, pharmacokinetic, and ...
Status
Completed
Location
Investigational Site
Start Date
2021-11-09
Trial ID
NCT05117554
Treatments Being Tested
This is a single-institution, pilot study of oral casdatifan, a selective H...
Status
Not Yet Recruiting
Location
Vanderbilt University Medical Center
Start Date
2029-07-01
Trial ID
NCT07748988
Treatments Being Tested
The purpose of the study is to compare the single dose PK of casdatifan bet...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08
Trial ID
NCT07751250
Treatments Being Tested
The purpose of the study is to assess the effects of multiple doses of itra...
Status
Completed
Location
Celerion
Start Date
2025-05-02
Trial ID
NCT06919991
Treatments Being Tested
The primary purpose of this study is to compare the single-dose pharmacokin...
Status
Completed
Location
Celerion, Inc.
Start Date
2023-08-21
Trial ID
NCT05999513
Treatments Being Tested